checkAd
    Startseite > Aktien > LAVA Therapeutics > Nachrichten
    LAVA Therapeutics Aktie
    2,8600
     
    EUR
    -2,72 %
    -0,0800 EUR
    Letzter Kurs 10.05.24 Tradegate
    2,7800
     
    EUR
    724 STK
    Geldkurs 10.05.24
    2,9400
     
    EUR
    680 STK
    Briefkurs 10.05.24
    ISIN: NL0015000AG6 · WKN: A2QSJY · SYM: 4PKB · Niederlande

    Neueste Nachrichten

    LAVA Therapeutics to Participate in the Citizens JMP Life Sciences Conference
    06.05.24 · globenewswire · LAVA Therapeutics
    LAVA Provides Business Updates and Reports Fourth Quarter and Year-End Financial Results
    20.03.24 · globenewswire · LAVA Therapeutics
    LAVA Announces Clinical Development Milestone Achieved by Pfizer for PF-08046052 (formerly SGN-EGFRd2/LAVA-1223)
    05.03.24 · globenewswire · LAVA Therapeutics
    LAVA Therapeutics und Fate Therapeutics: Weitere +400% für sharedeals.de-User
    01.03.24 · Sharedeals · LAVA Therapeutics
    LAVA Therapeutics-Aktie +43%: Was ist da los?
    26.01.24 · Sharedeals · LAVA Therapeutics
    LAVA Therapeutics Announces Collaboration with Merck & Co., Inc., Rahway, NJ, USA to Evaluate LAVA-1207 in Combination with KEYTRUDA
    25.01.24 · globenewswire · LAVA Therapeutics
    Lava Therapeutics Provides Business Update and Reports Third Quarter 2023 Financial Results
    16.11.23 · globenewswire · LAVA Therapeutics
    LAVA Therapeutics to Participate in the H.C. Wainwright 25th Annual Global Investment Conference
    06.09.23 · globenewswire · LAVA Therapeutics
    LAVA Therapeutics Provides Business Update and Reports Second Quarter 2023 Financial Results
    22.08.23 · globenewswire · LAVA Therapeutics
    LAVA Therapeutics to Participate in the H.C. Wainwright Immune Cell Engager Virtual Conference
    14.08.23 · globenewswire · LAVA Therapeutics
    LAVA Therapeutics Provides Updates on Clinical Programs and Extends the Cash Runway
    14.06.23 · globenewswire · LAVA Therapeutics
    LAVA Therapeutics Provides Business Update and Reports First Quarter 2023 Financial Results
    08.06.23 · globenewswire · LAVA Therapeutics